Vericel raises $20M in stock offering
Insight Weekly: Loan delinquencies up; US money supply falls; coal employment grows
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Vericel Corp. raised about $20 million after closing a previously announced public offering.
The company issued 7,130,000 shares at $2.75 apiece, inclusive of the overallotment option for additional 930,000 stocks.
Funds raised will help the company advance its drug pipeline.
Piper Jaffray & Co. acted as manager for the offering.
